| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.43 | 0.1 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.32 | 0.1 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.19 | 0.4 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.18 | 0.6 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.03 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.15 | 0.08 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.15 | 0.4 |